Drug treatment of anxiety and depression in detoxified alcoholic patients.
D000437:Alcoholism / Q000628:therapy*; D000639:Amitriptyline / Q000008:administration & dosage / Q000627:therapeutic use*; D000704:Analysis of Variance; D001007:Anxiety / Q000188:drug therapy*; D001205:Ascorbic Acid / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000008:administration & dosage / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004522:Educational Status; D006801:Humans; D007361:Intelligence Tests; D008653:Mesoridazine / Q000008:administration & dosage / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use; D011581:Psychological Tests; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D014803:Vitamin B Complex / Q000627:therapeutic use
D014803:Vitamin B Complex; D000639:Amitriptyline; D008653:Mesoridazine; D010672:Phenytoin; D002707:Chlordiazepoxide; D001205:Ascorbic Acid